<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03429192</url>
  </required_header>
  <id_info>
    <org_study_id>TJ-N2LC-01</org_study_id>
    <nct_id>NCT03429192</nct_id>
  </id_info>
  <brief_title>A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer</brief_title>
  <official_title>A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tianjin Chest Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LinkDoc Technology (Beijing) Co. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Tianjin Chest Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to compare patient survivals in the N2 patients with non-small cell lung cancer in
      the subgroups of lymph skip metastases and non-skip metastases
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multi-centre real-world non-interventional observational study to retrospectively collect
      the study data on patient demographic/tumor biological characteristics and clinical
      treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in
      the subgroups of lymph skip metastases and non-skip metastases.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">March 30, 2018</completion_date>
  <primary_completion_date type="Actual">March 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in overall survival (OS)</measure>
    <time_frame>2014 - 2017</time_frame>
    <description>OS difference in the subgroups of N2 patients with lymph skip metastases and non-skip metastases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of N2 patients with lymph skip metastases</measure>
    <time_frame>2014 - 2017</time_frame>
    <description>Percentage of N2 patients with lymph skip metastases</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Difference in overall survival (OS) (in the subgroups of patients)</measure>
    <time_frame>2014 - 2017</time_frame>
    <description>OS difference in subgroups of patients with lymph skip metastases and non-skip metastases categorised by baseline characteristics</description>
  </other_outcome>
  <other_outcome>
    <measure>Hazard factors of overall survival</measure>
    <time_frame>2014 - 2017</time_frame>
    <description>Hazard factors of overall survival</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2653</enrollment>
  <condition>Non-small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>N2 non-small cell lung cancer</arm_group_label>
    <description>Chinese patients with N2 non-small cell lung cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <description>Surgeries plus dissection of lymph nodes</description>
    <arm_group_label>N2 non-small cell lung cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pathologically diagnosed Chinese NSCLC patients with chest surgeries and lymphadenectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with surgeries from 2014 to 2017;

          -  Pathologically diagnosed patients with non-small cell lung cancer;

          -  Age &gt; 18 years old;

          -  Patients with chest surgeries before hospitalization;

          -  Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group
             10 and 11 lymph nodes);

        Exclusion Criteria:

        - Patients with radiotherapies, chemotherapies and biological therapies for tumors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xun Zhang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tianjin Chest Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>China People's Liberation Army Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henan Cancer Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital Affiliated to Huaxi Technology University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jiangsu Cancer Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Chest Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xi'an Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanghai</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huaxi Hospital Affiliate to Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Hospital Affiliated to Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2018</study_first_submitted>
  <study_first_submitted_qc>February 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2018</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tianjin Chest Hospital</investigator_affiliation>
    <investigator_full_name>Lingyu Huang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Chinese, real-world evidences, NSCLC, lymph skip metastases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

